OnKure Therapeutics, Inc.
OKUR
$2.61
-$0.01-0.38%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/11/2025
-
TipRanks Financial Blog
11/7/2025
-
TipRanks Financial Blog
11/6/2025
-
The Fly
11/6/2025
-
GuruFocus
11/6/2025
-
GuruFocus
11/6/2025
-
The Fly
11/6/2025
-
Globe Newswire
11/4/2025
-
GuruFocus
11/4/2025
-
Globe Newswire
10/8/2025
-
Ticker Report
9/24/2025
-
ETF Channel
9/13/2025
-
Ticker Report
8/26/2025
-
GuruFocus
8/26/2025
-
Ticker Report
8/22/2025
-
ETF Channel
8/18/2025
-
TipRanks Financial Blog
8/12/2025
-
GuruFocus
8/12/2025
-
GuruFocus
8/12/2025
-
TipRanks Financial Blog
8/12/2025
-
The Fly
8/12/2025
-
Globe Newswire
7/23/2025
-
Simply Wall St
7/22/2025
-
ETF Channel
7/21/2025
-
Ticker Report
5/28/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
720 307 2892
Address
6707 Winchester Circle
Boulder, CO 80301
Boulder, CO 80301
Country
Year Founded
--
Business Description
Sector
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its...
more